Funding
EAH
The study was funded by The Wellcome Trust (223016/Z/21/Z). The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. P1vital Products Ltd was the trial sponsor. EAH also received funding from the Swedish Research Council (2020–00873), OAK Foundation (OCAY-18-442), AFA Försäkring (200,342), The Lupina Foundation and Rannís, The Icelandic Research Fund. TJ also received funding from the UK Medical Research Council (MC_UU_00002/14). Open access funding provided by Uppsala University.